Although rapamycin was not tested in these last 3 citations, the HD-PD movement disorders axis demonstrates the duality of PI3K/Akt/mTOR pathway involvement in various neurodegenerations and the need to tailor treatment if this is to be targeted. The gene discussed is MTOR; the disease is Parkinson disease.